The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer’s Disease: Current Status and Prospects for Future Studies

Author(s): Daniel L.A. van den Hove, Leonidas Chouliaras, Bart P.F. Rutten

Journal Name: Current Alzheimer Research

Volume 9 , Issue 5 , 2012

Become EABM
Become Reviewer


Epigenetic modifications have been proposed to underlie age-related dysfunction and associated disorders. 5- hydroxymethylcytosine (5-hmC) is a newly described epigenetic modification. It is generated by the oxidation of 5- methylcytosine (5-mC) by the ten-eleven translocation (TET) family of enzymes. Various studies have shown that 5-hmC is present in high levels in the brain. Its lower affinity to methyl-binding proteins as compared to 5-mC suggests that it might have a different role in the regulation of gene expression, while it is also implicated in the DNA demethylation process. Interestingly, various widely used methods for DNA methylation detection fail to discriminate between 5-hmC and 5-mC, while numerous specific techniques are currently being developed. Recent studies have indicated an increase of 5-hmC with age in the mouse brain as well as an age- and gene-expression-level–related enrichment of 5-hmC in genes implicated in neurodegeneration. These findings suggest that 5-hmC may play an important role in the etiology and course of age-related neurodegenerative disorders. The present perspective summarizes the current knowledge on 5-hmC, discusses methodological challenges related to its detection, and suggests future strategies for examining the functional role of this epigenetic modification and its possible implication in aging and Alzheimer’s disease.

Keywords: Aging, Alzheimer’s disease, epigenesis, epigenetics, 5-hydroxymethylcytosine, DNA, hydroxymethylation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [545 - 549]
Pages: 5
DOI: 10.2174/156720512800618008
Price: $65

Article Metrics

PDF: 17